Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

22.94
-3.0600-11.77%
Pre-market: 22.36-0.5800-2.53%04:16 EST
Volume:50.15M
Turnover:1.17B
Market Cap:5.35B
PE:-36.82
High:25.67
Open:25.25
Low:22.73
Close:26.00
52wk High:42.70
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:4.14
T/O Rate:23.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:16.52
PE(LYR):44.78

Loading ...

Revenue Up 49%. Hims Shares Down 11.8%. What Went Wrong?

Bellwether Stocks Movement
·
8 hours ago

Hims & Hers Cuts 2026 Profit Forecast as Margins Contract

Reuters
·
8 hours ago

Hims & Hers Health Shares Dip 2.9% Premarket After Co Narrows 2026 Revenue Forecast

THOMSON REUTERS
·
6 mins ago

Dow Jones Top Company Headlines at 11 PM ET: the Spy Scandal That Lays Bare Nvidia's Governance Vacuum | Anthropic ...

Dow Jones
·
5 hours ago

24H | Take-Two Jumps 5%; Trade Desk Gains 3%; Nvidia Climbs 1%; Rocket Lab Sinks 7%; Hims & Hers Falls 3%

US Overnight
·
8 hours ago

Stocks to Watch: JBS, Hims & Hers Health, Skydance, Rocket Lab

Dow Jones
·
9 hours ago

Hims & Hers' Climbing Costs Weigh on Outlook

Dow Jones
·
10 hours ago

NASDAQ Net Change Percentage Gainers & Losers

Dow Jones
·
10 hours ago

Hims' Awaiting Testing, Sourcing Standards from Regulators Before Launching Bpc-157, CEO Says - Conf Call

THOMSON REUTERS
·
11 hours ago

Hims & Hers to Launch Peptide Products in November, CEO Says - Conf Call

THOMSON REUTERS
·
11 hours ago

Hims & Hers Health, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary

Reuters
·
11 hours ago

Hims' Menopause Therapies, Testosterone Testing Drove Boosted Revenue Per Subscriber for the Third Quarter, CFO Says

THOMSON REUTERS
·
11 hours ago

Hims Intentionally Paced Marketing Spending for Weight-Loss Drugs in Third Quarter, Ahead of Expansions, CFO Says

THOMSON REUTERS
·
11 hours ago

Hims & Hers to Offer Unapproved Peptides After US Eases Curbs

Reuters
·
11 hours ago

GUIDANCE: (HIMS) Hims & Hers Health Now Expects 2026 Revenue Range $3.13B - $3.15B, vs. FactSet Est of $3.21B

MT Newswires Live
·
11 hours ago

Earnings Flash (HIMS) Hims & Hers Health Posts Q3 Loss $0.14, vs. FactSet Est of $0.06

MT Newswires Live
·
11 hours ago

Hims & Hers Health Q3 EPS $(0.14) Misses $0.08 Estimate, Sales $890.373M Miss $892.888M Estimate

Benzinga Earnings
·
11 hours ago

Hims & Hers Forecasts Q4 Revenue Below Estimates as Gross Margin Falls

Reuters
·
12 hours ago

Hims & Hers Swings to Q3 2026 Net Loss of $33.04 Million; Q3 2026 Revenue Rises 49% to $890.37 Million

Reuters
·
12 hours ago

Movement Alert|Hims & Hers Health Inc. Falls 8.59% in After-Hours Trading, Market Continues to Digest Earnings and Prior Controversies

Market Focus
·
12 hours ago